AACE 2020: After 3 to 5 Years, Long-Term Bisphosphonate Therapy Should Be Reconsidered
Rare events such as atypical femoral fractures can cause chronic debility.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.